Literature DB >> 7964843

In vitro effects of polyvalent immunoglobulin for intravenous use.

I N van Schaik1, M Vermeulen, A Brand.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7964843      PMCID： PMC1016716          DOI： 10.1136/jnnp.57.suppl.15

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  46 in total

1.  Evidence for immunosuppression by high-dose gammaglobulin.

Authors:  K Kawada; P I Terasaki
Journal:  Exp Hematol       Date:  1987-02       Impact factor: 3.084

2.  Cytotoxic leucocyte iso-antibodies formed during the first pregnancy.

Authors:  J Overweg; C P Engelfriet
Journal:  Vox Sang       Date:  1969-02       Impact factor: 2.144

3.  Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis.

Authors:  L Cook; J F Howard; J D Folds
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

4.  Effect of commercial immunoglobulin G preparation on human monocyte Fc-receptor dependent binding of antibody coated platelets.

Authors:  M Saleh; W Court; W Huster; D Shaw; A LoBuglio
Journal:  Br J Haematol       Date:  1988-01       Impact factor: 6.998

5.  Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

Authors:  J Fehr; V Hofmann; U Kappeler
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

Review 6.  Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeutic.

Authors:  I Lundkvist; P A van Doorn; M Vermeulen; M van Lint; J J van Rood; A Brand
Journal:  Immunol Rev       Date:  1989-08       Impact factor: 12.988

7.  High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.

Authors:  E Nobile-Orazio; N Meucci; S Barbieri; M Carpo; G Scarlato
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

8.  Reversible and irreversible loss of Fc receptor function of human monocytes as a consequence of interaction with immunoglobulin G.

Authors:  R J Kurlander
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

9.  Experience with intravenous immunoglobulin in myasthenia gravis.

Authors:  E Arsura
Journal:  Clin Immunol Immunopathol       Date:  1989-11

10.  Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.

Authors:  D Y Leung; J C Burns; J W Newburger; R S Geha
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808
View more
  6 in total

1.  New therapeutic perspectives for demyelinating retrobulbar optic neuritis.

Authors:  B Currò Dossi; A Amadori; C Cirafisi; S Lorusso; M Pasquinelli; M G Piscaglia; A Ravasio
Journal:  Ital J Neurol Sci       Date:  1998-02

Review 2.  Immunomodulatory action of intravenous immunoglobulin.

Authors:  W A C Sewell; S Jolles
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 3.  Clinical uses of intravenous immunoglobulin.

Authors:  S Jolles; W A C Sewell; S A Misbah
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  In vivo modulation of cytokine synthesis by intravenous immunoglobulin.

Authors:  W A Sewell; M E North; R Cambronero; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 5.  Immunoglobulin for multifocal motor neuropathy.

Authors:  Stephen Keddie; Filip Eftimov; Leonard H van den Berg; Ruth Brassington; Rob J de Haan; Ivo N van Schaik
Journal:  Cochrane Database Syst Rev       Date:  2022-01-11

6.  In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency.

Authors:  Hasibe Artac; Reyhan Kara; Ismail Reisli
Journal:  Clin Exp Med       Date:  2010-03       Impact factor: 3.984
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.